GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 51 filers reported holding GEMINI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,555,000 | -3.0% | 5,826,223 | -0.0% | 0.18% | -0.6% |
| Q2 2022 | $9,846,000 | +21.6% | 5,826,224 | 0.0% | 0.18% | +35.9% |
| Q1 2022 | $8,098,000 | -52.2% | 5,826,224 | 0.0% | 0.13% | -39.9% |
| Q4 2021 | $16,954,000 | -28.0% | 5,826,224 | 0.0% | 0.22% | -15.8% |
| Q3 2021 | $23,538,000 | -37.6% | 5,826,224 | 0.0% | 0.26% | -32.0% |
| Q2 2021 | $37,696,000 | -52.3% | 5,826,224 | 0.0% | 0.38% | -48.4% |
| Q1 2021 | $78,945,000 | – | 5,826,224 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $32,996,000 | 9.70% |
| Opaleye Management Inc. | 810,500 | $10,982,000 | 1.61% |
| Altium Capital Management LP | 203,995 | $2,764,000 | 0.77% |
| Orbimed Advisors | 5,826,224 | $78,945,000 | 0.74% |
| Endurant Capital Management LP | 169,876 | $2,302,000 | 0.60% |
| Boxer Capital, LLC | 1,300,000 | $17,615,000 | 0.60% |
| DAFNA Capital Management LLC | 150,000 | $2,033,000 | 0.48% |
| JS Capital Management LLC | 474,457 | $6,429,000 | 0.33% |
| Ikarian Capital, LLC | 684,379 | $9,273,000 | 0.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,312,363 | $17,783,000 | 0.26% |